博洛克治疗急性脑梗塞223例疗效观察  

Treatment of Ischemic Cerebrovascular Disease with Lumbrokinase:An Observation of Therapeutic Effectiveness

作　　者：庞式琪[1] 丁铭臣[1] 谢淑萍[1] 柴锡庆 

机构地区：[1]首都医学院宣武医院神经内科

出　　处：《首都医学院学报》1993年第3期196-199,共4页

摘　　要：采用随机抽样双盲法应用博洛克治疗223例急性脑梗塞患者,总有效率为93.72%,显效率70.40%,治疗组纤维蛋白原、优球蛋白溶解时间、全血粘度、血浆粘度、血小板聚集功能均有下降,未发现任何毒副作用.Lumbrokinase is a new antithrombotic drug.We have treated 223 patients with cerebral infarction using this drug.Random sampling and double blind method were adopted.The re- sults revealed that the total effective rate was 93.72%,with the obvious effective rate being 70.40%.Fibrogen,euglobulin lysis time,blood viscosity,plasma viscosity and platelet aggre- gating function were reduced in the treated group.The side effect hasn't be found,thus, lumbrokinase is a nontoxic and safe drug.

关 键 词：蚓激酶 脑栓塞 抗凝血药 博洛克 

分 类 号：R973.2[医药卫生—药品]